Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their...
Systsje Anne Bergstra, PhD, from Leiden University Medical Center answers our questions about her study that compared DMARD treatment regimens among patients with rheumatoid arthritis who failed initial...
Corrine Voils, MD, from Williams S. Middleton Memorial Veterans Hospital and Wisconsin School of Medicine and Public Health, discusses her latest research paper about the myths of medication adherence. ...
Michael Banks, MD, discusses a recent study that details the inconsistencies of antiviral treatment in children hospitalized with an influenza infection, despite recommendations from the Centers for Disease...
Edmond J. LaVoie, PhD, discusses a new antibiotic that specifically targets variants of the MRSA bacteria, and should be able to circumvent the problem of antibiotic resistance in certain bacterial...
Juan Pablo Frias, MD, discusses an FDA-approved medication option that will help reduce blood sugar levels in conjunction with diet and exercise in patients with type 2 diabetes.
This video details a study of how patients with type 2 diabetes who also have liver cirrhosis associated with hepatitis C virus infection fare when treated with metformin.
Paul J. Pockros, MD, assesses the use and limitations of triple therapy in specific patient populations such as patients with cirrhosis, transplant recipients, and patients who are coinfected with HIV. ...
